Division of Hematology, Oncology and Transplantation
-
Committed to providing the highest quality care based on cutting edge research to patients with cancer or non-malignant hematologic diseases such as sickle cell disease
-
Dedicated to advancing research on the biological underpinnings of cancer, stem cell biology, sickle cell anemia, endothelial cell biology, and tumor immunology
-
Over 50 full-time academic investigators involved in interdisciplinary research and patient care are devoted to training the next generation of academic leaders
Announcements
Marshall Mazepa, MD, was nominated for a prestigious 2019 Charles C. Shepard Science Award. Since 1985, the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR) have presented the Shepard Science Award to authors of the most outstanding peer-reviewed research articles published by CDC/ATSDR scientists during the preceding year. As a nominated author, Dr. Mazepa will be honored for his special contribution to the mission of CDC/ATSDR and to public health. The winners in four different categories—Assessment, Prevention and Control, Laboratory Science, and Data Methods and Study Design—will be revealed at a ceremony on June 26, 2019. Dr. Mazepa was nominated for his investigations into risk factors that predict clinical bleeding severity in patients with hemophilia. Dr. Mazepa’s study results were published in an August 2018 issue of Blood Advances in an article entitled, “The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.” Please join us in congratulating Dr. Mazepa on his nomination for a Shepard Science Award.
June 2019
Aimee Merino, MD, PhD, received a 2019 Young Investigator Award from the American Society of Clinical Oncology’s Conquer Cancer Foundation. The Young Investigator Award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of the grant is to fund physicians during the transition from a training program to a faculty appointment. Dr. Merino is currently a trainee in two training programs in the University of Minnesota Medical School: the Fellowship Training Program in Hematology, Medical Oncology and Transplantation directed by Yvonne Datta, MD, and the Hematology T32 Research Training Program directed by Greg Vercellotti, MD. With the support of the Young Investigator Award, Dr. Merino will continue her research into new immunotherapies for patients with kidney cancer. Please join us in congratulating Dr. Merino on being selected to receive a 2019 Young Investigator Award!
May 2019
See more Faculty and Trainee Accomplishments